3D Printing: first cancer drug
A group of researchers at Parabon NanoLabs firm has developed a new drug to combat a type of brain cancer. What is unique about this drug is that it is the first drug that has been printed in 3D , molecule by molecule, using a technique of self-assembly of DNA, a technique designed with a computer program. Scientists suggest that progress not only drastically reduces the time needed to create medicines, but also opens the door to entirely new drug designs.
The drug was developed by specialists of the company through two proprietary technologies: the platform for drug development Drug Development Plattform Essemblix Parabon and computer projection system Parabon inSequio Sequence Design Studio.
Researchers have the DNA molecule was instrumental in the development. The reason is that DNA, besides keeping the genetic information of individuals, contains a very valuable feature, organizing their chains are organized at the structural level. One detail that allowed for use as a principle other nanostructures, such as medicine. According to Steven Armetrout, lead developer of the project:
What sets our other nanotechnology is our ability to place every atom in the unit we created in place accurately and quickly.
As we said at the beginning, the particularity of the drug is that it was created through a 3D printer molecule by molecule. Prepared molecules are linked between them in the same way that DNA, a process which is required to join together the fragments needed to be found and then form a single structure.
Once inside the body, the preparation was directed to the epicenter of disease. Scientists have thanks to the combination of different technologies were able to produce millions of identical copies of the designed molecules needed, where the particles are located healing substances.
A future technology that could open the door to new drugs designs in record time.Tags: 3D Printing, cancer